BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25752309)

  • 1. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
    Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
    FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
    Guo N; Ling G; Liang X; Jin J; Fan J; Qiu J; Song Y; Huang N; Wu X; Wang X; Deng X; Deng X; Yu L
    Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of doxycycline and fluconazole against Candida albicans biofilms and the impact of calcium channel blockers.
    Gao Y; Zhang C; Lu C; Liu P; Li Y; Li H; Sun S
    FEMS Yeast Res; 2013 Aug; 13(5):453-62. PubMed ID: 23577622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
    Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
    Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods.
    Guo N; Wu X; Yu L; Liu J; Meng R; Jin J; Lu H; Wang X; Yan S; Deng X
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):193-201. PubMed ID: 19878317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation.
    Xu Y; Wang Y; Yan L; Liang RM; Dai BD; Tang RJ; Gao PH; Jiang YY
    J Proteome Res; 2009 Nov; 8(11):5296-304. PubMed ID: 19754040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms.
    Jia W; Zhang H; Li C; Li G; Liu X; Wei J
    BMC Microbiol; 2016 Jun; 16(1):113. PubMed ID: 27316338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal activity of Rubus chingii extract combined with fluconazole against fluconazole-resistant Candida albicans.
    Han B; Chen J; Yu YQ; Cao YB; Jiang YY
    Microbiol Immunol; 2016 Feb; 60(2):82-92. PubMed ID: 26891940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic antimicrobial β-peptide in dual-treatment with fluconazole or ketoconazole enhances the in vitro inhibition of planktonic and biofilm Candida albicans.
    Mora-Navarro C; Caraballo-León J; Torres-Lugo M; Ortiz-Bermúdez P
    J Pept Sci; 2015 Dec; 21(12):853-61. PubMed ID: 26470850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prenylated flavanone from Dalea elegans inhibits rhodamine 6 G efflux and reverses fluconazole-resistance in Candida albicans.
    Peralta MA; Calise M; Fornari MC; Ortega MG; Diez RA; Cabrera JL; Pérez C
    Planta Med; 2012 Jun; 78(10):981-7. PubMed ID: 22673834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents.
    Shi W; Chen Z; Chen X; Cao L; Liu P; Sun S
    FEMS Yeast Res; 2010 Nov; 10(7):885-93. PubMed ID: 20707818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
    Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
    J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole.
    Huang S; Cao YY; Dai BD; Sun XR; Zhu ZY; Cao YB; Wang Y; Gao PH; Jiang YY
    Biol Pharm Bull; 2008 Dec; 31(12):2234-6. PubMed ID: 19043205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
    Kobayashi T; Kakeya H; Miyazaki T; Izumikawa K; Yanagihara K; Ohno H; Yamamoto Y; Tashiro T; Kohno S
    Jpn J Infect Dis; 2011; 64(4):292-6. PubMed ID: 21788703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
    Li LP; Liu W; Liu H; Zhu F; Zhang DZ; Shen H; Xu Z; Qi YP; Zhang SQ; Chen SM; He LJ; Cao XJ; Huang X; Zhang JD; Yan L; An MM; Jiang YY
    PLoS One; 2015; 10(5):e0126393. PubMed ID: 25992630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
    Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
    Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery.
    Liu S; Hou Y; Chen X; Gao Y; Li H; Sun S
    Int J Antimicrob Agents; 2014 May; 43(5):395-402. PubMed ID: 24503221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata.
    Dovigo LN; Pavarina AC; Mima EG; Giampaolo ET; Vergani CE; Bagnato VS
    Mycoses; 2011 Mar; 54(2):123-30. PubMed ID: 19889173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.